MDR-Art.10 | General obligations of manufacturers (Article 10) | 2 |
MDR-Art.103_104_105_106_107_108 | Medical Device Coordination Group + EU expert panels + EU reference laboratories (Articles 103-108) | 0 |
MDR-Art.109_110_111_112_113_115 | Confidentiality, data protection, funding, civil liability and penalties (Articles 109-115) | 1 |
MDR-Art.11_12_13_14 | Authorised representative, importers and distributors (Articles 11-14) | 0 |
MDR-Art.120 | Transitional provisions (Article 120 as amended by (EU) 2023/607) | 2 |
MDR-Art.122_123 | Entry into force and date of application (Articles 122-123) | 0 |
MDR-Art.15 | Person Responsible for Regulatory Compliance (Article 15) | 1 |
MDR-Art.16 | Cases where manufacturer obligations apply to others (Article 16) | 0 |
MDR-Art.17_18 | Single-use device reprocessing and implant card (Articles 17-18) | 0 |
MDR-Art.19_20 | EU declaration of conformity and CE marking (Articles 19-20) | 1 |
MDR-Art.1_2_3_4 | Subject matter, scope, definitions and regulatory status (Articles 1-4) | 0 |
MDR-Art.21_22_23 | Special purposes, systems and procedure packs, parts and components (Articles 21-23) | 0 |
MDR-Art.25_27_28 | Supply-chain identification and UDI system (Articles 25, 27-28) | 1 |
MDR-Art.29_30_31 | Registration of devices and economic operators (Articles 29-31) | 1 |
MDR-Art.32_33 | Summary of Safety and Clinical Performance + EUDAMED (Articles 32-33) | 1 |
MDR-Art.35_36_37_38_39_40_41_42_45_46_47_50 | Notified bodies - authorities, requirements, subsidiaries, designations and re-assessment (Articles 35-50 selected) | 0 |
MDR-Art.51 | Classification of devices (Article 51 and Annex VIII) | 0 |
MDR-Art.52_54_55 | Conformity assessment, consultation procedure and scrutiny mechanism (Articles 52, 54, 55) | 0 |
MDR-Art.56_57 | Certificates of conformity and electronic system (Articles 56-57) | 0 |
MDR-Art.5_6_7 | Placing on market + distance sales + misleading claims (Articles 5-7) | 0 |
MDR-Art.61_62 | Clinical evaluation and clinical investigations general requirements (Articles 61-62) | 4 |
MDR-Art.70_74_75_80_82 | Clinical-investigation application + CE-marked-device studies + substantial modifications + adverse events + records (Articles 70, 74-75, 80, 82) | 1 |
MDR-Art.83 | Post-market surveillance system of the manufacturer (Article 83) | 2 |
MDR-Art.84_85_86 | PMS plan + PMS report + Periodic Safety Update Report (Articles 84-86) | 1 |
MDR-Art.87_88_89_90_91_92 | Vigilance + serious incident reporting + FSCAs + trend reporting (Articles 87-92) | 1 |
MDR-Art.93_94_95_96_97_98 | Market surveillance + Member-State competent authorities (Articles 93-98) | 0 |